Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05783297 · ClinicalTrials.gov registry record · NA
Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
A NA study of HIV Infections, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Active
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 12
- Study locations
NCT05783297: Active NA study of HIV Infections, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT05783297 is a NA study of HIV Infections that is active but no longer recruiting, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 600 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (35% higher). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05783297, a NA study of HIV Infections, is active but no longer recruiting, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 12
- Study locations
Study Summary
This research study uses a cluster randomized controlled trial design to evaluate the effectiveness of Treatment Text (TXTXT) intervention on adherence and viral load suppression at 3- and 6- months post intervention initiation for youth and young adults with HIV. A total of 12 clinics will be randomized into one of the following two conditions: 1. Comparison Arm (n=6 clinics)- Clinics randomized to the comparison arm will have participants receive the standard of care for 3 months, followed by a 3-month intervention period. 2. Intervention Arm (n=6 clinics)- Clinics randomized to the intervention arm will have participants receive the TXTXT intervention for 6 months.
Primary Outcome
A documented viral load measured by nucleic acid test (NAT) less than (\<) 200 copies/mL will be considered virally suppressed. The minimum value is 20 copies/mL and the maximum is 10,000,000 copies/mL. A higher value indicates a worse outcome. Time frame: 6 months, 12 months.
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Treatment Text (TXTXT)
Study Locations (12)
Illinois
- University of Illinois at Chicago - Chicago
- Howard Brown Health - Chicago
Indiana
- Eskenazi Health - Indianapolis
- Indiana University - Indianapolis
Texas
- Baylor College of Medicine - Houston
- Valley AIDS Council - McAllen
Florida
- AIDS Healthcare Foundation - Fort Lauderdale
Louisiana
- Comprehensive Care Center of Southwest Louisiana - Lake Charles
Michigan
- Corktown Health Center - Detroit
Missouri
- KC Care Health Center - Kansas City
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2023-04-17 |
| Est. Completion | 2025-08 |
| Phase | NA |
What the registry record for NCT05783297 still lists
NCT05783297 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (35% higher).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT05783297 lists 12 locations in 9 states (Illinois, Indiana, Texas).
Frequently Asked Questions
What is clinical trial NCT05783297 about?
NCT05783297 is a clinical study titled "Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence". This research study uses a cluster randomized controlled trial design to evaluate the effectiveness of Treatment Text (TXTXT) intervention on adherence and viral load suppression at 3- and 6- months post intervention initiation for youth and young adults with HIV. A total of 12 clinics will be rando...
What is the current status of trial NCT05783297?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2023-04-17. Estimated completion is 2025-08.
What conditions does trial NCT05783297 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT05783297?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Treatment Text (TXTXT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05783297?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05783297 being conducted?
This trial has 12 study locations across Florida, Illinois, Indiana, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05783297's enrollment target sits among peer trials
600 51st of 542 higher than 490 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI